Quick-acting Heart Reliever
Commercial- Indications
- Cardiovascular disease
Company intelligence / Profile preview
Tianjin Pacific Chemical & Pharmaceutical Co., Ltd. specializes in the R&D, manufacturing, and export of active pharmaceutical ingredients and intermediates. The company holds GMP certification from the SFDA and supplies over a dozen APIs globally. It has completed at least one clinical bioequivalence trial for Isosorbide Dinitrate Tablets. No proprietary new drugs or late-stage clinical assets are reported.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Pacific Chemical & Pharmaceutical Co., Ltd..